Charlottesville Tomorrow By: Josh Mandell Cavion, a Charlottesville biopharmaceutical company, sent shockwaves through Virginia’s startup scene with a recent announcement that it had raised $26.1 million in Series A venture investment. Andrew Krouse,...
By Josh Mandell(Charlottesville Tomorrow) Cavion, a Charlottesville biopharmaceutical company, sent shockwaves through Virginia’s startup scene with a recent announcement that it had raised $26.1 million in Series A venture investment. Andrew ...
From Business Wire: Cavion, Inc., announced today the closing of a $26.1 million venture financing. Lilly Ventures and Novartis Venture Fund co-led the investment round in tandem with Enso Ventures and additional participation of existing investors. ...
CHARLOTTESVILLE, Va.-- Cavion LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of neurologic diseases and solid tumor cancers, announced today that it has closed a $5 million private placement of convertibl...
The Virginia Biosciences Health Research Corporation (VBHRC/“the catalyst”) today announced that it has awarded $2.23 million in grants to five collaborative bioscience commercialization projects between Virginia’s research universities and private c...